Close

BridgeBio Pharma (BBIO) PT Raised to $79 at Jefferies After Reporting Positive Encaleret Ph2 Data

Go back to BridgeBio Pharma (BBIO) PT Raised to $79 at Jefferies After Reporting Positive Encaleret Ph2 Data
(NASDAQ: BBIO) Delayed: 24.74 -0.21 (0.84%)
Previous Close $24.95    52 Week High
Open $24.88    52 Week Low
Day High $25.36    P/E N/A 
Day Low $24.27    EPS
Volume 2,298,720